Literature DB >> 19255569

Breast cancer quality control.

Cam Patterson1, Sarah Ronnebaum.   

Abstract

Tumorigenesis is regulated by several mechanisms including signalling, transcription and DNA replication. Now a cytoplasmic protein quality-control pathway is implicated in the suppression of breast cancer cell growth, suggesting a new role for quality-control mechanisms in suppressing cells with malignant potential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255569     DOI: 10.1038/ncb0309-239

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  14 in total

Review 1.  CHIP: a link between the chaperone and proteasome systems.

Authors:  Holly McDonough; Cam Patterson
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

2.  CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.

Authors:  Hong Xin; Xialian Xu; Linyu Li; Hongxiu Ning; Yu Rong; Yu Shang; Yinyin Wang; Xin-Yuan Fu; Zhijie Chang
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

3.  CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control.

Authors:  Jin-Na Min; Ryan A Whaley; Norman E Sharpless; Pamela Lockyer; Andrea L Portbury; Cam Patterson
Journal:  Mol Cell Biol       Date:  2008-04-14       Impact factor: 4.272

4.  Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.

Authors:  Chad A Dickey; Mei Yue; Wen-Lang Lin; Dennis W Dickson; Judith H Dunmore; Wing C Lee; Cynthia Zehr; Gemma West; Songsong Cao; Amber M K Clark; Guy A Caldwell; Kim A Caldwell; Christopher Eckman; Cam Patterson; Michael Hutton; Leonard Petrucelli
Journal:  J Neurosci       Date:  2006-06-28       Impact factor: 6.167

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

Review 6.  Hsp90 inhibitors as novel cancer chemotherapeutic agents.

Authors:  Len Neckers
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

7.  Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.

Authors:  Yukiyo Tateishi; Yoh-ichi Kawabe; Tomoki Chiba; Shigeo Murata; Ken Ichikawa; Akiko Murayama; Keiji Tanaka; Tadashi Baba; Shigeaki Kato; Junn Yanagisawa
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

8.  SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

Authors:  Ray-Chang Wu; Qin Feng; David M Lonard; Bert W O'Malley
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

9.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress.

Authors:  Qian Dai; Chunlian Zhang; Yaxu Wu; Holly McDonough; Ryan A Whaley; Virginia Godfrey; Hui-Hua Li; Nageswara Madamanchi; Wanping Xu; Len Neckers; Douglas Cyr; Cam Patterson
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  3 in total

1.  New insights into TRAP1 pathway.

Authors:  Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Matteo Landriscina; Franca Esposito
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

2.  E3 ubiquitin ligase CHIP attenuates cellular proliferation and invasion abilities in triple-negative breast cancer cells.

Authors:  Jingjing Xu; Huan Wang; Wenjing Li; Kaili Liu; Tingli Zhang; Zhijie He; Feng Guo
Journal:  Clin Exp Med       Date:  2019-12-16       Impact factor: 3.984

Review 3.  Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.

Authors:  Ioannis A Voutsadakis
Journal:  Tumour Biol       Date:  2012-03-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.